A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Clinical trial NCT06666855 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06666855
- Sponsor
- Santen Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-28
- Primary completion
- 2026-08-31
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.